Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Kivu Bioscience Inc.
ViroMissile, Inc.
MacroGenics
City of Hope Medical Center
M.D. Anderson Cancer Center
HiFiBiO Therapeutics
Seattle Children's Hospital
Seattle Children's Hospital
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Valo Therapeutics Oy
Epkin
Eli Lilly and Company
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
Eli Lilly and Company
German Cancer Research Center
IGM Biosciences, Inc.
TopAlliance Biosciences
Shanghai PerHum Therapeutics Co., Ltd.
Shanghai PerHum Therapeutics Co., Ltd.
Emory University
Xencor, Inc.
Pfizer
DNAtrix, Inc.
National Cancer Institute (NCI)
Celon Pharma SA
Adaptimmune
Corvus Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, LLC
Sumitomo Pharma America, Inc.
Emory University
Children's National Research Institute
Tempest Therapeutics
Sorrento Therapeutics, Inc.
Prelude Therapeutics
Case Comprehensive Cancer Center
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Ludwig Institute for Cancer Research
MacroGenics
Seagen Inc.
Emory University
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Tocagen Inc.